Navigation Links
New Evidence Highlights Dangers of Mercury Toxicity in Fish
Date:10/8/2008

SAN FRANCISCO, Oct. 8 /PRNewswire/ -- Dr. Jane Hightower -- widely acknowledged as the first US physician to recognize low-level mercury poisoning in patients who regularly consume certain types of fish -- today released new evidence showing that the FDA has failed to inform and protect the public from the risks of mercury poisoning due to consumption of certain types of seafood. Dr. Hightower has released a new book, Diagnosis: Mercury: Money, Politics, and Poison, which is widely available in stores starting October 7, 2008.

"Common sense says that if you are not feeling well, and are eating poison, then stop eating it and see if you feel better," said Dr. Hightower. "The problem is that we are not given enough information about just how much mercury is in the fish that is widely available in stores and restaurants. Most American consumers are simply unaware that the fish they eat could be making them sick."

Using newly available legal testimony and investigative research into the source of the scientific data that inform the FDA's mercury consumption guidelines, Dr. Hightower has pulled together information that should concern everyone in the United States.

The FDA's current mercury consumption guidelines are rooted in a study of the victims of a mass methylmercury poisoning in Saddam Hussein's Iraq. While researchers from the University of Rochester and the World Health Organization wrote articles about the effects of mercury on these victims, Dr. Hightower shows that their conclusions were based on data provided by one of Hussein's government allies. And this associate in Iraq's health ministry -- who oversaw the study of Iraqi victims of mercury toxicity -- has recently revealed that he withheld information from researchers, information that might have shown severe effects at much lower levels of exposure.

When the FDA and the swordfishing giant Anderson Seafood Inc. went to court in the mid-1970s over the FDA's consumption guidelines, Anderson used the Iraqi study as proof that high levels of mercury exposure are safe for the general public. The company won its case based on the evidence presented in court. But in the course of Dr. Hightower's research she discovered that one of the lead investigators of the Iraqi poisoning disputed the fishing industry's claim of how much mercury is safe to eat. Even as government agencies around the world -- including our own EPA -- have moved away from the "safe" levels based on the Iraq studies, the FDA has failed to adequately warn the public that mercury-laden seafood is a major threat to their health. The concern reaches far beyond women of childbearing age and children.

"Diagnosis: Mercury brings together the strongest evidence to date that the FDA's guidelines for fish consumption are insufficient," said Chuck Savitt, president of Island Press, which published the book. "We simply don't know how widespread low-level mercury toxicity is in the United States, and this book tells us that regular consumers of certain types of fish are in danger."

Hightower's research spans from individual patients in her practice to widespread mercury poisonings in Japan, Canada, and Iraq. Diagnosis: Mercury makes a powerful case for increased study and stronger FDA regulation of this poison in our food supply.


'/>"/>
SOURCE Island Press
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Evidence-Based Investing: M.D. Turned Financial Advisor Diagnoses What Ails Most Investors
2. DIA Conference to Provide New Paradigms in Evidence-Based Medicine and Health Technology Assessment
3. First Comprehensive Reference on Evidence-Based Design Published
4. Louisiana May Mandate Fluoridation Despite Evidence of Harm
5. Experts from 10 countries develop first evidence-based definition of lifelong premature ejaculation
6. Researchers find first conclusive evidence of Alzheimers-like brain tangles in nonhuman primates
7. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
8. Antidepressants do work in depression while evidence for CBT is poorer say experts
9. Evidence that stun guns may stimulate the heart
10. Promising early evidence of the superior benefits of drug therapy for diabetic eye disease
11. Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
Breaking Medicine Technology: